Intrexon | XON - Trade Creditors


Intrexon reported $4.85M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
Agenus USD 58.98M 12.1M Jun/2026
Alaunos Therapeutics USD 732K 332K Jun/2026
Amgen USD 20.83B 17.97B Sep/2026
Anika Therapeutics USD 6.24M 103K Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
AstraZeneca USD 23.57B 679M Sep/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Incyte USD 235.37M 1.16B Sep/2026
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
Ligand Pharmaceuticals USD 4.1M 5.31M Sep/2026
MacroGenics USD 3.44M 845K Jun/2026
MannKind USD 14.38M 3.34M Sep/2026
Merck USD 5.03B 1.2B Sep/2026
Novartis USD 4.24B 15M Sep/2026
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.54B 237M Jun/2026
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Thermo Fisher Scientific USD 3.09B 181M Sep/2026
Veracyte USD 9.71M 1.69M Sep/2026
Xencor USD 6.65M 6M Sep/2026